ADC Therapeutics announced that Peter Hug, Ph.D., will be appointed to its board of directors. Dr. Hug is a 35-year veteran of Roche. Dr. Hug held positions of increasing responsibility at Roche from 1983 until his retirement at the end of 2018. He most recently served as Head of Roche Pharma EEMEA Region, which comprises Eastern Europe, Russia, Central Asia, Turkey, Middle East and Africa.